Common flu vaccine primarily based on mRNA expertise to be examined by NIH
A woman receives a booster dose of Moderna coronavirus vaccine (COVID-19) at a vaccination center in Antwerp, Belgium, February 1, 2022.Johanna Geron | ReutersThe National Institutes of Health announced Monday that patients are now…